Cybersecurity in the Age of Connected Medical Devices

By AHRMM

AHRMM Webinar Image

 

Price: Member: FREE  |  Non-Member: $99.00

CEC Hours: 1

Order Webinar

  

Description:

Cybersecurity impacts all industry verticals including health care. Health care organizations need to address security in standard technology and medical devices. The Mayo Clinic has made a significant effort to reduce the risk to critical medical device infrastructure posed by cyber-attacks. During this webinar, Debra Bruemmer shares eight key practices straight from Mayo’s cybersecurity strategy that reduce organizational risk, with a focus on the role supply chain professionals can play in supporting cybersecurity efforts.

How this session relates to the Cost, Quality, and Outcomes (CQO) Movement: Cost savings related to time and money will improve when electronic medical devices have a cybersecurity plan in place.

 

Learning Objectives:
  • Discuss how a medical device security program can aid in identifying vulnerable devices, assessing associated risk, and formulating an action plan.
  • Describe eight practices that can be included in a medical device security program and can reduce cybersecurity risk to your medical device fleet.
  • Explain how collaboration between providers and vendors is key to ensuring patient safety in a technology-dependent health care environment.

 

Target Audience:

Health care supply chain leaders, IT managers, strategic sourcing directors, and purchasing managers.

 

Presenter:
  • Debra Bruemmer — Senior Manager Office of Information Security, Mayo Clinic

 

Related Resources

Advisory
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.
Request for Proposals (RFP)
A sample of request for proposal for contractors to provide uniformed healthcare security services.
Request for Proposals (RFP)
A sample of wholesale pharmacy distributor request for proposal.
Senior Contract Specialist job description.
Letter/Comment
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo